Answers are grounded in this paper and cite their sources.
A newly devised route to the Pfizer drug nirmatrelvir is reported that reduces the overall sequence to a 1-pot process and relies on a commercially available, green coupling reagent, T3P. The overall yield of the targeted material, isolated as its MTBE solvate, is 64%.
No takes yet. Share an insight, caveat, or question.
Caravez et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: